当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析 - 现金流量表

华仁药业

(300110)

  

流通市值:34.84亿  总市值:34.88亿
流通股本:11.81亿   总股本:11.82亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金252,466,216.051,374,072,879.31,017,402,754.76658,962,409.11
  收到的税费返还0024,482.8124,482.81
  收到其他与经营活动有关的现金10,306,300.1621,194,538.4122,773,540.1614,429,701.85
  经营活动现金流入小计262,772,516.211,395,267,417.711,040,200,777.73673,416,593.77
  购买商品、接受劳务支付的现金141,329,836.79487,941,266.69385,984,593.85254,440,232.15
  支付给职工以及为职工支付的现金73,991,454.5306,498,419.34228,464,155.35146,423,853.35
  支付的各项税费25,178,415.15119,119,178.0589,055,665.662,678,512.34
  支付其他与经营活动有关的现金8,004,589.8891,475,024.480,073,199.5540,032,339.21
  经营活动现金流出小计248,504,296.321,005,033,888.48783,577,614.35503,574,937.05
  经营活动产生的现金流量净额14,268,219.89390,233,529.23256,623,163.38169,841,656.72
二、投资活动产生的现金流量:
  收回投资收到的现金-99.8--
  取得投资收益收到的现金-360,505.35--
  处置固定资产、无形资产和其他长期资产收回的现金净额-22,00000
  处置子公司及其他营业单位收到的现金净额-1,706,659.761,706,659.761,706,659.76
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-2,089,264.911,706,659.761,706,659.76
  购建固定资产、无形资产和其他长期资产支付的现金4,873,854.0248,980,335.2943,063,009.3136,065,817.68
  取得子公司及其他营业单位支付的现金--0-
  投资活动现金流出小计4,873,854.0248,980,335.2943,063,009.3136,065,817.68
  投资活动产生的现金流量净额-4,873,854.02-46,891,070.38-41,356,349.55-34,359,157.92
三、筹资活动产生的现金流量:
  取得借款收到的现金422,874,854.09538,845,250470,945,250445,515,250
  收到其他与筹资活动有关的现金-90,000,00090,000,00090,000,000
  筹资活动现金流入小计422,874,854.09628,845,250560,945,250535,515,250
  偿还债务支付的现金371,085,020885,245,497.51607,887,297.51523,883,192.51
  分配股利、利润或偿付利息支付的现金9,565,834.1547,942,004.7938,615,429.6923,263,526.05
  其中:子公司支付给少数股东的股利、利润-5,478,895.29--
  支付其他与筹资活动有关的现金-90,455,00090,335,00090,000,000
  筹资活动现金流出小计380,650,854.151,023,642,502.3736,837,727.2637,146,718.56
  筹资活动产生的现金流量净额42,223,999.94-394,797,252.3-175,892,477.2-101,631,468.56
四、汇率变动对现金及现金等价物的影响-1,322.484,666.744,875.375,084.8
五、现金及现金等价物净增加额51,617,043.33-51,450,126.7139,379,21233,856,115.04
  加:期初现金及现金等价物余额95,349,627.11146,799,753.82146,799,753.82146,799,753.82
  期末现金及现金等价物余额146,966,670.4495,349,627.11186,178,965.82180,655,868.86
补充资料:
  净利润--459,389,075.8-39,164,980.62
  资产减值准备-586,124,422.53-11,582,247.29
  固定资产和投资性房地产折旧-84,646,779.18-42,562,421.87
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-84,646,779.18-42,562,421.87
  无形资产摊销-23,350,563.04-11,103,453.9
  长期待摊费用摊销-8,222,408.05-4,460,281.28
  处置固定资产、无形资产和其他长期资产的损失--7,332.49--
  固定资产报废损失-284,860.15-44,149.19
  财务费用-41,969,585.59-21,235,172.89
  投资损失--2,340,718.11--2,298,173.26
  递延所得税--16,796,250.09--3,678,118.1
  其中:递延所得税资产减少--13,803,260.09--2,154,897.46
    递延所得税负债增加--2,992,990--1,523,220.64
  存货的减少-56,255,873.85-38,353,357.45
  经营性应收项目的减少-51,629,011.19--31,316,744.06
  经营性应付项目的增加-15,812,318.25-38,419,574.06
  现金的期末余额-95,349,627.11-180,655,868.86
  减:现金的期初余额-146,799,753.82-146,799,753.82
  现金及现金等价物的净增加额--51,450,126.71-33,856,115.04
公告日期2026-04-242026-04-242025-10-302025-08-16
审计意见(境内)标准无保留意见
TOP↑